28.20
+0.24(+0.86%)
Currency In USD
Address
221 Crescent Street Building 23, Suite 105
Menlo Park, MA
United States of America
Phone
203-554-7604
Website
Sector
Healthcare
Industry
Biotechnology
Employees
28
First IPO Date
N/A
| Name | Title | Pay | Year Born |
| Dr. Lawrence Otto Klein Ph.D. | President, Chief Executive Officer & Director | 520,911 | 1983 |
| Mr. Paul T. Quinlan | General Counsel & Secretary | 310,445 | 1963 |
| Dr. Joana Goncalves M.D. | Chief Medical Officer | 317,986 | 1974 |
| Mr. Alan Lada | Vice President of Investor Relations | 0 | N/A |
| Dr. Rajiv Panwar | Vice President and Head of Chemistry, Manufacturing & Controls | 0 | N/A |
| Dr. Joe Senn Ph.D. | Senior Vice President of Nonclinical Research & Development | 0 | N/A |
| Ms. Laura Sandler | Senior Vice President of Operations & Boston Site Head | 0 | N/A |
| Mr. Arjun Agarwal CPA | Senior Vice President of Finance & Treasurer | 0 | 1976 |
| Mr. Christopher Finch | Vice President of Corporate Development & Strategy | 0 | N/A |
Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.